💊
Abraxane
paclitaxel
Neoplasias de mama;Neoplasias pancreáticas;Carcinoma de pulmón no microcítico
✅ Autorizado
✅
No hay alertas activas
Este medicamento no tiene escasez en curso, cartas de seguridad ni retiradas del mercado.
Para qué se utiliza
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Seguridad del paciente
No
📚 Alertas pasadas (2)
Página oficial de la EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/abraxane